PMID: 22353003Feb 23, 2012Paper

Emerging drugs for the treatment of Human Immunodeficiency virus

Recent Patents on Anti-infective Drug Discovery
Girish M Bhopale

Abstract

Rapid emergence of drug resistant Human Immunodeficiency virus (HIV) variants and severe side effects of anti-HIV drugs limit the efficacy of existing anti-HIV therapies. Efforts are being made to develop newer anti-HIV agents. Few newer anti-HIV agents reached the different clinical phases of development and appear promising for future therapy. The present article highlights the current status of available anti-HIV drugs, emerging anti-HIV drug agents and recent anti-HIV drugs patents information.

Citations

Oct 1, 2014·Antimicrobial Agents and Chemotherapy·Odalis Asin-MilanCécile L Tremblay
Aug 7, 2018·Cutaneous and Ocular Toxicology·Yan-Yan WangYa-Juan Zheng
Oct 20, 2020·Frontiers in Immunology·Hajer AounallahMichail Kotsyfakis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Recent Patents on Anti-infective Drug Discovery
Baldeep Wirk
Recent Patents on Anti-infective Drug Discovery
Philippe Cotelle
Recent Patents on Anti-infective Drug Discovery
Dipti Gothi, Jyotsna M Joshi
© 2022 Meta ULC. All rights reserved